Daniel G. Coit

Active 1983–2025

162
Papers
36,672
Citations
99
h-index
160
i10-index

Citations

Citations per year for Daniel G. Coit1984: 4 citations1985: 15 citations1986: 10 citations1987: 9 citations1988: 12 citations1989: 5 citations1990: 12 citations1991: 19 citations1992: 13 citations1993: 10 citations1994: 9 citations1995: 29 citations1996: 16 citations1997: 22 citations1998: 26 citations1999: 53 citations2000: 71 citations2001: 88 citations2002: 161 citations2003: 186 citations2004: 197 citations2005: 195 citations2006: 254 citations2007: 213 citations2008: 232 citations2009: 271 citations2010: 243 citations2011: 304 citations2012: 266 citations2013: 274 citations2014: 249 citations2015: 238 citations2016: 208 citations2017: 222 citations2018: 245 citations2019: 858 citations2020: 814 citations2021: 702 citations2022: 452 citations2023: 304 citations2024: 495 citations2025: 204 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,024 citing papers, 28.8% of this breakdownChina: 850 citing papers, 8.1% of this breakdownItaly: 681 citing papers, 6.5% of this breakdownGermany: 638 citing papers, 6.1% of this breakdownUnited Kingdom: 587 citing papers, 5.6% of this breakdownAustralia: 480 citing papers, 4.6% of this breakdownNetherlands: 427 citing papers, 4.1% of this breakdownFrance: 412 citing papers, 3.9% of this breakdownJapan: 395 citing papers, 3.7% of this breakdownCanada: 302 citing papers, 2.9% of this breakdownSpain: 232 citing papers, 2.2% of this breakdownSouth Korea: 217 citing papers, 2.1% of this breakdown
0%28.8%Other 21.4%

Fields

  • Medicine77.2%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Immunology and Microbiology3.5%
  • Health Professions0.8%
  • Engineering0.7%
  • Computer Science0.5%
  • Other1.8%

Topics

  • Cutaneous Melanoma Detection and Management9.2%
  • Gastric Cancer Management and Outcomes5.3%
  • Melanoma and MAPK Pathways5.2%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Nonmelanoma Skin Cancer Studies3.3%
  • Immunotherapy and Immune Responses3.1%
  • Other70%

Coauthors

All papers

Open in search
  1. Final Version of 2009 AJCC Melanoma Staging and Classification

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 4,570

  2. Hereditary diffuse gastric cancer: updated clinical practice guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Parry, Jeremy Rossaak, Haruhiko Sugimura, Magali Svrcek, Marc Tischkowitz, Toshikazu Ushijima, Hidetaka Yamada, Han‐Kwang Yang, Adrian Claydon, Joana Figueiredo, Karyn Paringatai, Raquel Seruca, Nicola Bougen‐Zhukov, Tom P. Brew, Simone Busija, Patrı́cia Carneiro, Lynn DeGregorio, Helen Fisher, Erin R. Gardner, Tanis Godwin, Katharine Nichole Holm, Bostjan Humar, C.J. Lintott, Elizabeth C. Monroe, Mark D Muller, Enrique Norero, Yasmin Nouri, Joana Paredes, João Sanches, Emily Schulpen, Ana Sofia Ribeiro, Andrew Sporle, James Whitworth, Liying Zhang, Anthony E. Reeve, Parry Guilford - The Lancet Oncology 2020 cited by 480

  3. Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Hyman, Maurizio Scaltriti, Marc Ladanyi, Neal Rosen, David H. Ilson, Michael F. Berger, Laura H. Tang, Barry S. Taylor, David B. Solit, Nikolaus Schultz - Cancer Discovery 2017 cited by 382

  4. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project

    Authors: , , , , , , , - Gastric Cancer 2016 cited by 496

  5. A Nomogram That Predicts the Presence of Sentinel Node Metastasis in Melanoma With Better Discrimination Than the American Joint Committee on CancerStaging System

    Authors: , , , - Annals of Surgical Oncology 2005 cited by 195

  6. High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy

    Authors: , , , , , , , - Cancer 2019 cited by 142

  7. A Novel Microbiome Signature in Gastric Cancer

    Authors: , , , , , , , , , , , - Annals of Surgery 2022 cited by 51

  8. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 2,401

  9. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2019 cited by 438

  10. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hugo Pinheiro, Krish Ragunath, Esther Rasenberg, Susan Richardson, Franco Roviello, Hans K. Schackert, Raquel Seruca, Amy Taylor, Anouk ter Huurne, Marc Tischkowitz, Sheena Tjon A Joe, Benjamin van Dijck, Nicole C.T. van Grieken, Richard van Hillegersberg, Johanna W. van Sandick, Rianne Vehof, J. Han van Krieken, Rebecca C. Fitzgerald - Journal of Medical Genetics 2015 cited by 564

  11. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2001 cited by 2,654

  12. Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

    Authors: , , , , , , , , , , , - Cancer Medicine 2018 cited by 127

  13. Prognostic Gene Expression Profiling in Cutaneous Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John M. Kirkwood, David H. Lawson, Philip D. Leming, Georgina V. Long, Ashfaq A. Marghoob, Janice M. Mehnert, Michael E. Ming, Kelly C. Nelson, David Polsky, Richard A. Scolyer, Eric A. Smith, Vernon K. Sondak, Mitchell Stark, Jennifer Stein, John A. Thompson, John F. Thompson, Suraj Venna, Maria L. Wei, Susan M. Swetter - JAMA Dermatology 2020 cited by 93

  14. Quality of Life After Gastrectomy for Adenocarcinoma

    Authors: , , , , , - Annals of Surgery 2013 cited by 148

  15. Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma

    Authors: , , , , , , , , , - JAMA Dermatology 2020 cited by 56

  16. Liver resection for colorectal metastases.

    Authors: , , , , , , , , , - Journal of Clinical Oncology 1997 cited by 1,295

  17. Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

    Authors: , , , , - Journal of Clinical Oncology 2010 cited by 255

  18. Patterns of detection in patients with cutaneous melanoma

    Authors: , , , , , , - Cancer 2000 cited by 234

  19. Prognosis of Acral Melanoma: A Series of 281 Patients

    Authors: , , , , , , - Annals of Surgical Oncology 2013 cited by 153

  20. Risk of Lymph Node Metastasis in T1b Gastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Surgery 2021 cited by 32

  21. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status

    Authors: , , , , , , , , , , , , , - JAMA Surgery 2024 cited by 29

  22. Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2013 cited by 176

  23. A prospective evaluation of the utility of 2‐deoxy‐2‐[18F]fluoro‐D‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer

    Authors: , , , , , , - Cancer 2012 cited by 143

  24. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype

    Authors: , , , - The American Journal of Surgical Pathology 2019 cited by 63